Xiaobin Cao
Henan Institute Of Medical And Pharmaceutical Sciences & Henan Key Medical Laboratory Of Tumor Molecular Biomarkers
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Anti-PDGFRα autoantibody - a novel diagnostic and prognostic marker - may mediate non-small cell lung cancer progression via the PI3K/AKT/NF-κB signaling pathway.
Journal: British journal of cancer
Published: September 02, 2026
Anti-PDGFRα autoantibody - a novel diagnostic and prognostic marker - may mediate non-small cell lung cancer progression via the PI3K/AKT/NF-κB signaling pathway.
Journal: British journal of cancer
Published: July 01, 2025
CXCL12/ZNF503/GATA3/MMP1 axis promotes tumor progression and metastasis of triple-negative breast cancer.
Journal: Breast cancer research : BCR
Published: June 20, 2025
Plasma anti-PRTN3 IgG and IgM autoantibodies: novel biomarkers for early detection of lung adenocarcinoma.
Journal: Frontiers in immunology
Published: November 25, 2024
Anti-FDX1 Autoantibody as a Potential Biomarker for Non-Small Cell Lung Cancer Detection.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: July 28, 2024
Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer.
Journal: Frontiers in immunology
Published: June 26, 2024
ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: April 10, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026